Cellular Dynamics, AstraZeneca Ink Stem Cell Partnership | GenomeWeb

NEW YORK (GenomeWeb News) – Cellular Dynamics today said that it will collaborate with AstraZeneca on developing new human induced pluripotent stem cells for therapeutic discovery screening applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.